z-logo
open-access-imgOpen Access
Placental Growth Factor as an Indicator of Maternal Cardiovascular Risk After Pregnancy
Author(s) -
Laura Benschop,
Sarah SchalekampTimmermans,
Zoe A. Broere-Brown,
Jeanine E. Roeters van Lennep,
Vincent W. V. Jaddoe,
Jolien W. RoosHesselink,
M. Kamran Ikram,
Eric A.P. Steegers,
James M. Roberts,
Robin E. Gandley
Publication year - 2019
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.118.036632
Subject(s) - medicine , pregnancy , obstetrics , preeclampsia , placental growth factor , gestational age , population , gestational hypertension , quartile , blood pressure , confidence interval , genetics , environmental health , biology
Angiogenic placental growth factor (PlGF) concentrations rise during pregnancy, peaking at the end of midpregnancy. Low PlGF concentrations during pregnancy are associated with pregnancy complications with recognized later-life cardiovascular risk. We hypothesized that low PlGF concentrations, especially in midpregnancy, identify not only a subset of women at risk for pregnancy complications but also women with greater cardiovascular risk factor burden after pregnancy regardless of pregnancy outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom